<SEC-DOCUMENT>0001193125-19-242991.txt : 20190911
<SEC-HEADER>0001193125-19-242991.hdr.sgml : 20190911
<ACCEPTANCE-DATETIME>20190911163209
ACCESSION NUMBER:		0001193125-19-242991
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20190909
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190911
DATE AS OF CHANGE:		20190911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		191088616

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d795128d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehc="http://www.encompasshealth.com/20190909" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2019-09-09_to_2019-09-09">Encompass Health Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2019-09-09_to_2019-09-09">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2019-09-09_to_2019-09-09">0000785161</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ehc-20190909.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2019-09-09_to_2019-09-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-09-09</xbrli:startDate> <xbrli:endDate>2019-09-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, DC 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:10pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2019-09-09_to_2019-09-09">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:10pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the<span style="text-transform:uppercase">&#32;</span>Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:10pt">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt:datemonthdayyearen">September&#160;9, 2019</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:10pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Encompass Health Corporation</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact Name of Registrant as specified in Charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or Other Jurisdiction of Incorporation)</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:10pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:50%;"></td>
<td style="width:1%;"></td>
<td style="width:48%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2019-09-09_to_2019-09-09">001-10315</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2019-09-09_to_2019-09-09">63-0860407</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer Identification No.)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2019-09-09_to_2019-09-09">9001 Liberty Parkway</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2019-09-09_to_2019-09-09">Birmingham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:stateprovnameen">Alabama</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2019-09-09_to_2019-09-09">35242</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of Principal Executive Offices, including Zip Code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2019-09-09_to_2019-09-09">(205)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2019-09-09_to_2019-09-09">967-7116</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s Telephone Number, including Area Code)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:10pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2019-09-09_to_2019-09-09">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2019-09-09_to_2019-09-09">EHC</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934. Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2019-09-09_to_2019-09-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;1.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Entry into a Material Definitive Agreement.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On September&#160;9, 2019, Encompass Health Corporation (the &#8220;Company&#8221;) and certain of its subsidiaries, as guarantors (&#8220;Guarantors&#8221;), entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Citigroup Global Markets Inc., acting on behalf of itself and as representative of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), and the Underwriters, pursuant to which the Company agreed to issue and sell to the Underwriters $500,000,000 aggregate principal amount of the Company&#8217;s 4.500% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and $500,000,000 aggregate principal amount of the Company&#8217;s 4.750% Senior Notes due 2030 (the &#8220;2030 Notes&#8221; and, together with the 2028 Notes, the &#8220;Notes&#8221;) in an underwritten public offering (&#8220;Offering&#8221;). The Notes have been offered pursuant to a prospectus supplement dated September&#160;9, 2019, to the prospectus dated September&#160;18, 2017, that forms a part of the Company&#8217;s effective Registration Statement on Form <span style="white-space:nowrap">S-3,</span> as amended (File No.<span style="white-space:nowrap">&#160;333-220519),</span> filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended. The Offering is expected to close on or about September&#160;18, 2019, subject to the satisfaction of customary closing conditions. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Underwriting Agreement contains customary representations, warranties and covenants of the Company and the Guarantors, conditions to closing, indemnification obligations of the Company and the Guarantors and the Underwriters and termination and other customary provisions. The foregoing description of the Underwriting Agreement is not intended to be complete and is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and is incorporated herein by reference. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Underwriters and certain of their affiliates have performed, and may in the future perform, various commercial and investment banking and financial advisory services for the Company and its affiliates, for which they have received or may in the future receive customary fees and expenses. The underwriters and/or certain of their affiliates act as agents and/or lenders under the Company&#8217;s credit agreement and receive and are expected to receive customary fees for their services as well as reimbursement for certain expenses. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;8.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Other Events.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On September&#160;9, 2019, the Company issued a press release announcing the pricing of the Offering. The Company&#8217;s press release is filed as Exhibit 99.1 hereto, and is incorporated herein by reference. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;">(d)&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Exhibits</td> </tr> </table>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:CENTER;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Exhibit<br />Number </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:CENTER;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description of Exhibit </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;1.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d795128dex11.htm">Underwriting Agreement, dated September&#160;9, 2019, by and among Encompass Health Corporation, its subsidiary guarantors named therein, Citigroup Global Markets Inc., as representative for the underwriters named therein and for itself, and Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs&#160;&#038; Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley&#160;&#038; Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">99.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d795128dex991.htm">Press Release of Encompass Health Corporation, dated September&#160;9, 2019 </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File &#8211; the cover page iXBRL tags are embedded within the Inline XBRL document </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <div style="float:right;width:100%">
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:40%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:0px">
<tr>
<td style="width:12%;"></td>
<td style="width:1%;"></td>
<td style="width:87%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">ENCOMPASS HEALTH CORPORATION </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ <span style="font-variant:small-caps">Douglas E. Coltharp</span></p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Douglas E. Coltharp </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President and Chief Financial Officer </p> </td> </tr> </table> </div> <div style="clear:both"></div> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Date: September 11, 2019 </p> <div></div> <p style="margin-top:0"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d795128dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,000,000,000 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENCOMPASS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4.500% Senior Notes due 2028 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4.750% Senior Notes due 2030 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">New York, New York </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;9, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets
Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Representative of the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Several Underwriters listed
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regions Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SunTrust Robinson Humphrey, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10013 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation, a corporation organized under the laws of Delaware (the &#147;<U>Company</U>&#148;), proposes to issue and sell
to the several Underwriters listed in Schedule 1 hereto (the &#147;<U>Underwriters</U>&#148;), for whom you are acting as representative (the &#147;<U>Representative</U>&#148;), $500,000,000 aggregate principal amount of the Company&#146;s 4.500%
Senior Notes due 2028 (the &#147;<U>2028 Notes</U>&#148;) and $500,000,000 aggregate principal amount of the Company&#146;s 4.750% Senior Notes due 2030 (the &#147;<U>2030 Notes</U>&#148; and, together with the 2028 Notes, the
&#147;<U>Securities</U>&#148;). The Securities will be issued pursuant to the indenture (the &#147;<U>Base Indenture</U>&#148;) dated as of December&nbsp;1, 2009, between the Company and Wells Fargo Bank, National Association (successor to The Bank
of Nova Scotia Trust Company of New York), as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by the eighth supplemental indenture thereto relating to the 2028 Notes and the ninth supplemental indenture thereto relating to the 2030 Notes,
each to be dated as of the Closing Date, among the Company, the subsidiary guarantors party thereto and the Trustee (the &#147;<U>Supplemental Indentures</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), and will be
guaranteed on an unsecured senior basis by each of the Guarantors listed in Schedule 2 hereto (the &#147;<U>Guarantors</U>,&#148; and such guarantees the &#147;<U>Guarantees</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">This Underwriting Agreement (this &#147;<U>Agreement</U>&#148;), the Indenture (including each Guarantee set forth therein) and the
Securities are herein referred to collectively as the &#147;<U>Transaction Documents</U>.&#148; The issuance and sale of the Securities and the issuance of the Guarantees together with all transactions contemplated herein and in the Disclosure
Package and the Final Prospectus are herein referred to collectively as the &#147;<U>Transactions</U>.&#148; </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary
Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> which were filed under the Exchange Act on or
before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms &#147;amend,&#148; &#147;amendment&#148;
or &#147;supplement&#148; with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the
Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. Certain terms used herein are defined in
Section&nbsp;22 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. The Company and the Guarantors jointly and
severally represent and warrant to, and agree with, the several Underwriters that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Statement and Prospectus</U>. The Company meets the requirements for use of <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Act and has prepared and filed with the Commission an automatic shelf registration statement (No. <FONT STYLE="white-space:nowrap">333-220519),</FONT> as defined in Rule 405, on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> including a related Base Prospectus, for registration under the Act of the offering and sale of the Securities. Such Registration Statement, including any amendments thereto filed prior to the
Execution Time, became effective upon filing and has been filed with the Commission not earlier than three years prior to the Closing Date. The Company has filed with the Commission, as part of an amendment to the Registration Statement or pursuant
to Rule 424(b), one or more preliminary prospectus supplements relating to the Securities, each of which has previously been furnished to the Underwriters. The Company will file with the Commission a final prospectus supplement relating to the
Securities in accordance with Rule 424(b). Except to the extent the Underwriters shall agree in writing to a modification, such final prospectus supplement shall be in all substantive respects in the form furnished to the Underwriters prior to the
Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company has advised
the Underwriters, prior to the Execution Time, will be included or made therein. The Registration Statement, at the Execution Time, meets the requirements set forth in Rule&nbsp;415(a)(1)(x). No order suspending the effectiveness of the Registration
has been issued by the Commission and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Act against the Company or related to the offering has been instituted or, to the Company&#146;s knowledge, threatened by the Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with the Act and the Exchange Act</U>. On each Effective Date, the Registration
Statement did, and when the Preliminary Prospectus and Final Prospectus are first filed in accordance with Rule&nbsp;424(b) and on the Closing Date, the Preliminary Prospectus and Final Prospectus (and any supplement thereto) will, each comply in
all material respects with the applicable requirements of the Act, the Exchange Act and the Trust Indenture Act, and the respective rules and regulations thereunder; on each Effective Date and at the Execution Time, the Registration Statement did
not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on the date of any filing pursuant to
Rule&nbsp;424(b) and on the Closing Date, the Final Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Company makes no representations or warranties as to the information contained in or omitted from the Registration Statement or the
Final Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in the Registration Statement or the Final Prospectus
(or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Negative Assurance</U>. (i)&nbsp;The
Disclosure Package, when taken together as a whole as of the Execution Time and (ii)&nbsp;each electronic road show (if any) when taken together as a whole with the Disclosure Package as of the Execution Time, do not contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions
from the Disclosure Package based upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for use therein, it being understood and agreed that the only such information furnished by
or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Status as Well-Known Seasoned Issuer</U>. (i)&nbsp;At the time of filing the Registration
Statement, (ii)&nbsp;at the time of the most recent amendment thereto for the purposes of complying with Section&nbsp;10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or
15(d) of the Exchange Act or form of prospectus), (iii)&nbsp;at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption
in Rule 163, and (iv)&nbsp;at the Execution Time (with such date being used as the determination date for purposes of this clause (iv)), the Company was or is (as the case may be) a &#147;well-known seasoned issuer&#148; as defined in Rule 405. The
Company agrees to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Not an Ineligible Issuer</U>. (i)&nbsp;At the earliest time after the filing of the Registration
Statement that the Company or another offering participant made a <I>bona fide </I>offer (within the meaning of Rule 164(h)(2)) of the Securities and (ii)&nbsp;as of the Execution Time (with such date being used as the determination date for
purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered
an Ineligible Issuer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>No Objection to Automatic Shelf</U>. The Company has not received from
the Commission any notice pursuant to Rule&nbsp;401(g)(2) objecting to use of the automatic shelf registration statement form. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus does not include any information
that conflicts with the information contained in the Registration Statement, including any document incorporated therein by reference and any prospectus supplement deemed to be a part thereof that has not been superseded or modified. The foregoing
sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for use therein, it being
understood and agreed that the only such information furnished by or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Accounting Firm</U>. To the Company&#146;s knowledge, PricewaterhouseCoopers LLP, who
has audited the financial statements included in the Disclosure Package and the Final Prospectus, other than the unaudited pro forma condensed combined financial statements discussed in paragraph (i)&nbsp;below, is an independent registered public
accounting firm with respect to the Company and its subsidiaries within the meaning of the Act and the rules and regulations thereunder and the rules and regulations of the Public Company Accounting Oversight Board (the &#147;<U>PCAOB</U>&#148;).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>. The financial statements, together with the related schedules and
notes, included or incorporated by reference in the Disclosure Package and the Final Prospectus present fairly the financial position of the Company and its consolidated subsidiaries at the dates indicated and the statement of operations,
stockholders&#146; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles
(&#147;<U>GAAP</U>&#148;) applied on a consistent basis throughout the periods involved and comply as to form with the applicable accounting requirements of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Act. The supporting
schedules, if any, included in the Disclosure Package and the Final Prospectus present fairly in accordance with GAAP the information required to be stated therein. The selected financial data included in, and the summary financial information in
the &#147;Capitalization&#148; section of, the Disclosure Package and the Final Prospectus present fairly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included in the Disclosure Package and the Final Prospectus. The
interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the Disclosure Package and the Final Prospectus fairly present the information called for in all material respects and have been
prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in
the Disclosure Package and the Final Prospectus, except as otherwise stated therein, (i)&nbsp;there has been no material adverse change in the condition (financial or otherwise), or in the earnings or business affairs of the Company and its
subsidiaries considered as one enterprise whether or not arising in the ordinary course of business (a &#147;<U>Material Adverse Effect</U>&#148;), and (ii)&nbsp;there have been no transactions entered into by the Company or any of its subsidiaries
other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Formation and Powers</U>. The Company has been duly organized and is validly existing
as a corporation in good standing under the laws of the State of Delaware and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Disclosure Package and the Final Prospectus,
to enter into and perform its obligations under each of the Transaction Documents and for the consummation of the Transactions; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other
jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not result in a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiary Formation and Powers</U>. Each subsidiary of the Company has been duly
organized and is a validly existing corporation, limited liability company or limited partnership, as the case may be, in good standing under the laws of the jurisdiction of its incorporation or formation, has the corporate, limited liability
company or limited partnership power and authority to own, lease and operate its properties and to conduct its business as described in the Disclosure Package and the Final Prospectus and is duly qualified as a foreign corporation, limited liability
company or limited partnership, as the case may be, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business,
except where the failure so to qualify or to be in good standing would not result in a Material Adverse Effect; except as otherwise disclosed in the Disclosure Package and the Final Prospectus or as would not result in a Material Adverse Effect, all
of the issued and outstanding capital stock or other equity interests of each subsidiary of the Company has been duly authorized and validly issued, is fully paid and, to the extent applicable, <FONT STYLE="white-space:nowrap">non-assessable</FONT>
and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity; none of the outstanding shares of capital stock of the subsidiaries of the Company was
issued in violation of any preemptive or similar rights of any security holder of such subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;<U>Due Execution of Transaction Documents</U>. Each Transaction Document has been duly authorized,
executed and delivered by the Company and each of the Guarantors party thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;<U>Indenture
Authorization and Enforceability</U>. The Base Indenture has been duly authorized and executed by the Company and the Supplemental Indentures have been duly authorized by the Company and each of the Guarantors and, upon effectiveness of the
Registration Statement, the Indenture was duly qualified under the Trust Indenture Act. The Base Indenture was duly executed and delivered by and constitutes a valid and binding obligation of the Company and the Supplemental Indentures, when
executed and delivered by the parties thereto, will constitute a valid and binding obligation of the Company and each of the Guarantors party thereto, in the case of the Base Indenture and each of the Supplemental Indentures, enforceable against
each of them in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers) or similar laws affecting the enforcement of
creditors&#146; rights generally or by equitable principles relating to enforceability (regardless of whether enforcement is considered in a proceeding in equity or at law) (collectively, the &#147;<U>Enforceability Exceptions</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities Authorization and
Enforceability</U>. The Securities have been duly authorized by the Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding
and will constitute valid and legally binding obligations of the Company enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the
Guarantees have been duly authorized by each of the Guarantors and, when the Securities have been duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be valid and legally binding
obligations of each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;<U>Conformity to Disclosure</U>. Each Transaction Document and each of the Transactions conform in
all material respects to the description thereof contained in the Disclosure Package and the Final Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;<U>Violation of Laws</U>. None of the Company or any of its subsidiaries is in violation of any law,
ordinance, governmental rule, regulation or court decree to which it is or its properties or assets may be subject, including federal Medicare and Medicaid statutes or any regulations promulgated pursuant to such statutes, or other federal, state or
local healthcare statutes or regulations, or has failed to obtain or maintain any license, permit, certificate, franchise or other governmental authorization or permit necessary to the ownership of its properties or to the conduct of its business,
except for such violations or failures that would not, individually or in the aggregate, result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;<U>Violation of Material Agreements</U>. Neither the Company nor any of its subsidiaries is in
violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar governing documents) or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture,
mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which any of them may be bound, or to which any of the property or assets of the Company
or any subsidiary is subject (collectively, &#147;<U>Agreements and Instruments</U>&#148;) except for such defaults that would not result in a Material Adverse Effect, and would not materially and adversely affect the consummation of the
Transactions or the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents; and the execution, delivery and performance of the Transaction Documents, the consummation of the Transactions and
compliance by the Company and the Guarantors with their respective obligations in connection therewith, have been duly authorized by all necessary corporate, limited liability company or limited partnership action and do not and will not, whether
with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any
property or assets of the Company or any of its subsidiaries pursuant to, the Agreements and Instruments except for such conflicts, breaches or defaults or Repayment Events or liens, charges or encumbrances that, singly or in the aggregate, would
not result in a Material Adverse Effect, and would not materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents, nor will
such action result in any violation of the provisions of (i)&nbsp;the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar governing documents) of the Company or any of its subsidiaries or (ii)&nbsp;any applicable law, statute,
rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Company or any of its subsidiaries or any of their assets, properties or operations except,
with respect to clause&nbsp;(ii) only, such violations that would not, singly or in the aggregate, result in a Material Adverse Effect, and would not materially and adversely affect the consummation of the Transactions or the performance by the
Company or the Guarantors of their respective obligations under the Transaction Documents. As used herein, a &#147;<U>Repayment Event</U>&#148; means any event or condition which gives the holder of any note, debenture or other evidence of
indebtedness (or any person acting on such holder&#146;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor</U>. No labor dispute with the employees of the Company or any of its subsidiaries exists
or, to the knowledge of the Company, is threatened, which, in either case, would result in a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;<U>Inquiry or Investigation</U>. Except as
described in the Disclosure Package and the Final Prospectus, there is no action, suit, proceeding, inquiry, arbitration or investigation before or brought by any court or governmental agency or body, domestic or foreign, or arbitrator or other
person, now pending, or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries (including rate appeals, recoupment claims or contests or open or unsettled cost reports, or claims or assertions made
in any utilization reviews), which would result in a Material Adverse Effect, or which might materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations
under the Transaction Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stabilization</U>. The Company and its affiliates have not
taken, directly or indirectly, any action designed to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property</U>. The Company and its subsidiaries own or possess adequate rights to use
all patents, patent rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks, trade names or other intellectual property (collectively, &#147;<U>Intellectual Property</U>&#148;) described in the Disclosure Package and the Prospectus as being necessary to carry on the business now operated by them,
except where the failure to own or possess such Intellectual Property, singly or in the aggregate, would not result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of any infringement of or
conflict with asserted rights of others with respect to any Intellectual Property and which infringement or conflict, singly or in the aggregate, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;<U>Approvals</U>. No filing with, or authorization, approval, consent, license, order, registration,
qualification or decree of, any court or governmental authority or agency is required for the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents or in connection with the consummation of the
Transactions, except such as have been already obtained or would not materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations under the Transaction
Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;<U>Licenses</U>. The Company and the Guarantors possess such permits, licenses,
approvals, rights to participate in, or the benefit of valid agreements to participate in, Medicare, Medicaid and other third-party payor programs, consents, accreditations and other authorizations (collectively, &#147;<U>Governmental
Licenses</U>&#148;) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except where the failure to so possess would not, singly or in the aggregate, result
in a Material Adverse Effect; and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any such Governmental Licenses which, singly or in the aggregate, if the subject
of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;<U>Internal Controls</U>. The Company and its subsidiaries maintain a system of internal control
over financial reporting (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> under the Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company&#146;s principal
executive officer and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
GAAP. Such system of internal control over financial reporting was evaluated for effectiveness and was effective as of the date of the latest audited financial statements included or incorporated by reference in the Disclosure Package or the Final
Prospectus and the Company and its subsidiaries are not aware of any material weaknesses in such internal control over financial reporting. Since the date of the latest audited financial statements included or incorporated by reference in the
Disclosure Package and the Final Prospectus, there has been no change in the Company&#146;s internal control over financial reporting that has materially adversely affected or is reasonably likely to materially adversely affect, the Company&#146;s
internal control over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Controls</U>. The Company maintains
disclosure controls and procedures (as such term is defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> under the Exchange Act) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have
been designed to ensure that material information relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and
procedures were evaluated for effectiveness and were effective as of the date of the latest financial statements included or incorporated by reference in the Disclosure Package or the Final Prospectus and since such evaluation, the Company has made
no significant changes in such system of disclosure controls and procedures or in other systems, processes or otherwise that could materially adversely affect such system of disclosure controls and procedures. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;<U>Real Property</U>. The Company and its subsidiaries have good and marketable title to, or have
valid rights to lease or otherwise use, all real property owned or used by the Company and its subsidiaries and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests,
claims, restrictions or encumbrances of any kind except such as (i)&nbsp;are described in the Disclosure Package and the Final Prospectus, (ii)&nbsp;do not, singly or in the aggregate, materially affect the value of such property and do not
interfere with the use made and proposed to be made of such property by the Company or any of its subsidiaries or (iii)&nbsp;would not, singly or in the aggregate, result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental</U>. Except as described in the Disclosure Package and the Final Prospectus and
except for such matters as would not, singly or in the aggregate, result in a Material Adverse Effect, (i)&nbsp;neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation,
or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
or petroleum products, asbestos-containing materials or mold (collectively, &#147;<U>Hazardous Materials</U>&#148;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials
(collectively, &#147;<U>Environmental Laws</U>&#148;), (ii)&nbsp;the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their requirements, and
(iii)&nbsp;there are no pending or, to the Company&#146;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings
relating to any Environmental Law against the Company or any of its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;<U>ERISA</U>. Except as described in the Disclosure Package and the Final Prospectus, none of the
following events has occurred or exists: (i)&nbsp;a failure to fulfill the obligations, if any, under the minimum funding standards of Section&nbsp;302 of the United States Employee Retirement Income Security Act of 1974, as amended
(&#147;<U>ERISA</U>&#148;), and the regulations and published interpretations thereunder with respect to a Plan, determined without regard to any waiver of such obligations or extension of any amortization period; (ii)&nbsp;an audit or investigation
by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other federal or state governmental agency or any foreign regulatory agency with respect to the employment or compensation of employees by
any of the Company or any of its subsidiaries that could have a Material Adverse Effect; or (iii)&nbsp;any breach of any contractual obligation, or any violation of law or applicable qualification standards, with respect to the employment or
compensation of employees by the Company or any of its subsidiaries that could have a Material Adverse Effect. Except as described in the Disclosure Package and the Final Prospectus, no event or condition giving rise to a liability under Title IV of
ERISA that could have a Material Adverse Effect has occurred. For purposes of this paragraph, the term &#147;<U>Plan</U>&#148; means a plan (within the meaning of Section&nbsp;3(3) of ERISA) subject to Title IV of ERISA with respect to which the
Company or any of its subsidiaries may have any liability. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign Corrupt Practices</U>.
None of (w)&nbsp;the Company or any of its subsidiaries, (x)&nbsp;to the Knowledge of the Company (as defined below), Alacare Home Health Services, Inc. d/b/a Alacare Home Health&nbsp;&amp; Hospice (&#147;<U>Alacare</U>&#148;) or any of its
subsidiaries (the &#147;<U>Alacare Companies</U>&#148;), (y) to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries or
(z)&nbsp;to the Knowledge of the Company, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of any of the Alacare Companies has (i)&nbsp;used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expense relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
political activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)&nbsp;violated or is in violation
of any provision of the Foreign Corrupt Practices Act of 1977; or (iv)&nbsp;made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. As used herein, &#147;Knowledge of the Company&#148; means the actual knowledge
obtained by the Company prior to the date hereof or prior to the Time of Delivery, as applicable based on the date on which a representation or warranty is made hereunder, from its due diligence investigation of Alacare in connection with the
Company&#146;s entry into that certain Asset Purchase Agreement, dated as of March&nbsp;29, 2019, by and among Alacare, certain subsidiaries of the Company and the various other parties named therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;<U>Money Laundering</U>. The operations of the Company and its subsidiaries and, to the Knowledge
of the Company, the Alacare Companies are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#147;<U>Money
Laundering Laws</U>&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries or, to the Knowledge of the Company, any of the Alacare
Companies with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp;<U>OFAC</U>. None of (w)&nbsp;the Company or any of its subsidiaries, (x)&nbsp;to the Knowledge of
the Company, any of the Alacare Companies (y)&nbsp;to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries or (z)&nbsp;to the Knowledge of the Company, any director, officer,
agent, employee or affiliate of any of the Alacare Companies is currently the subject of any&nbsp;sanctions administered or enforced by the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control (&#147;<U>Sanctions</U>&#148;); nor
is the Company or any of its subsidiaries located, organized or resident in a country, region or territory that is the subject of Sanctions; and the Company will not use the proceeds of the sale of the Securities, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other person, (i)&nbsp;directly or indirectly for the purpose of funding any activities of or business with any person, or in any country or territory, that, at the time of
such funding, is the subject of Sanctions or (ii)&nbsp;in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>. All United States federal income tax returns of the Company and its subsidiaries
required by law to be filed have been filed (except insofar as the failure to file such returns would not, singly or in the aggregate, result in a Material Adverse Effect) and all taxes shown by such returns or otherwise assessed, which are due and
payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. The Company and its subsidiaries have filed all other tax returns that are required to have
been filed by them pursuant to applicable foreign, state, local or other law (except insofar as the failure to file such returns would not, singly or in the aggregate, result in a Material Adverse Effect), and has paid all taxes due pursuant to such
returns or pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been provided. All material tax liabilities have been
adequately provided for in the financial statements of the Company to the extent required under GAAP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh)&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. The Company and its subsidiaries carry or are entitled to the benefits of
insurance in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business, and all such insurance is, to the Company&#146;s knowledge, in full force and effect. The
Company has no reason to believe that it or any subsidiary will not be able (i)&nbsp;to renew its existing insurance coverage as and when such policies expire or (ii)&nbsp;to obtain comparable coverage from similar institutions as may be necessary
or appropriate to conduct its business as now conducted and at a cost that will not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Statistical and Market Data</U>. Any statistical and market related data included in the
Disclosure Package and the Final Prospectus are based on or derived from sources that the Company believes to be reliable and accurate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj)&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Company</U>. Neither the Company
nor any of its subsidiaries is required, and upon the consummation of the Transactions, including the application of the net proceeds therefrom as described in the Disclosure Package and the Final Prospectus, none of them will be required, to
register as an &#147;investment company&#148; under the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk)&nbsp;&nbsp;&nbsp;&nbsp;<U>Solvency</U>. On and immediately after the Closing Date, the Company and the Guarantors (after
giving effect to the Transactions) will be Solvent. As used in this paragraph, the term &#147;<U>Solvent</U>&#148; means, with respect to a particular date, that on such date (i)&nbsp;the present fair market value (or present fair saleable value) of
the assets of the Company is not less than the total amount required to pay the liabilities of the Company on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii)&nbsp;the Company is
able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business; and (iii)&nbsp;assuming consummation of the Transactions, the Company is
not incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cybersecurity</U>. (i)&nbsp;(x) To the Company&#146;s knowledge, there has been no material
security breach or other material compromise of or relating to any of the Company&#146;s or its subsidiaries&#146; information technology and computer systems, networks, hardware, software, data (including the data of their respective customers,
employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (collectively, &#147;<U>IT Systems and Data</U>&#148;) and (y)&nbsp;the Company and its subsidiaries have not been notified of, and
have no knowledge of any event or condition that would reasonably be expected to result in, any material security breach or other material compromise to their IT Systems and Data, (ii)&nbsp;the Company and its subsidiaries are presently in
compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (ii), individually or in the aggregate, have a Material Adverse
Effect, and (iii)&nbsp;the Company and its subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any certificate signed by any officer of the Company or by an authorized signatory of a
Guarantor, and delivered to the Representative or counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company or such Guarantor, as applicable, as to matters covered
thereby, to each Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase and Sale</U>. Subject to the terms and conditions and in reliance
upon the representations and warranties herein set forth, the Company agrees to issue and sell the Securities to the several Underwriters, and each Underwriter agrees, severally and not jointly, to purchase from the Company, the respective principal
amount of Securities set forth opposite such Underwriter&#146;s name in Schedule 1 hereto at a price equal to (i) 98.50% of the principal amount of the 2028 Notes and (ii) 98.50% of the principal amount of the 2030 Notes, in each case, plus accrued
interest, if any, from September&nbsp;18, 2019 to the Closing Date. The Company will not be obligated to deliver any of the Securities except upon payment for all of the Securities to be purchased as provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery and Payment</U>. Delivery of and payment for the Securities shall be made not later than 10:00 a.m.,
New York time, on September&nbsp;18, 2019, or at such time on such later date not more than five Business Days after the foregoing date as the Representative shall designate, which date and time may be postponed by agreement between the
Representative and the Company (such date and time of delivery and payment for the Securities being herein called the &#147;<U>Closing Date</U>&#148;). Delivery of the Securities shall be made to the Underwriters against payment by the Underwriters
of the purchase price thereof to or upon the order of the Company by wire transfer payable in <FONT STYLE="white-space:nowrap">same-day</FONT> funds to an account specified by the Company. Delivery of the Securities shall be made through the
facilities of The Depository Trust Company unless the Representative shall otherwise instruct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Offering by
the Underwriters</U>. It is understood that the several Underwriters propose to offer the Securities for sale to the public as set forth in the Disclosure Package and the Final Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements</U>. The Company and the Guarantors jointly and
severally agree with the several Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments and Supplements to the
Registration Statement, Final Prospectus or Preliminary Prospectus; Preparation of Final Prospectus; Other Matters</U>. Prior to the termination of the offering of the Securities, the Company will not file any amendment of the Registration Statement
or supplement (including the Final Prospectus or any Preliminary Prospectus) (other than an amendment or supplement resulting from the filing of a report required to be filed by the Company under the Exchange Act or unless otherwise required by
applicable law; <U>provided</U>, <U>however</U>, that from the date hereof to the Closing Date, the Company shall furnish the counsel to the Underwriters with a copy of any Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that it
intends to file with the Commission prior to filing such report) to the Base Prospectus unless the Company has furnished the Underwriters with a copy for its review prior to filing and will not file any such proposed amendment or supplement to which
the Representative reasonably object in a reasonably timely manner. The Company will cause the Final Prospectus, properly completed, and any supplement thereto to be filed in a form approved by the Representative with the Commission pursuant to the
applicable paragraph of Rule&nbsp;424(b) within the time period prescribed and will provide evidence satisfactory to the Representative of such timely filing. The Company will promptly advise the Representative (i)&nbsp;when the Final Prospectus,
and any supplement thereto (if required), shall have been filed with the Commission pursuant to Rule&nbsp;424(b), (ii)&nbsp;when, prior to termination of the offering of the Securities, any amendment to the Registration Statement shall have been
filed or become effective, (iii)&nbsp;prior to the termination of the offering of Securities of any request by the Commission or its staff for any amendment of the Registration Statement or for any supplement to the Final Prospectus or for any
additional information, (iv)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any notice objecting to its use or the institution or threatening of any proceeding for that
purpose or pursuant to Section&nbsp;8A of the Act, (v)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction or the institution or threatening of any
proceeding for such purpose and (vi)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act. The
Company will use its reasonable best efforts to prevent the issuance of any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement and, upon such issuance, occurrence or notice of objection, to
obtain as soon as possible the withdrawal of such stop order or relief from such occurrence or objection, including, if necessary, by filing an amendment to the Registration Statement or a new registration statement and using its reasonable best
efforts to have such amendment or new registration statement declared effective as soon as practicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Package</U>. If, at any time prior to the filing of the Final Prospectus pursuant to
Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which
they were made or the circumstances then prevailing not misleading, or if it shall be necessary to amend the Disclosure Package, file a new registration statement or supplement the Disclosure Package to comply with the Act or the Exchange Act or the
respective rules thereunder, including in connection with use or delivery of the Disclosure Package, the Company will promptly (i)&nbsp;notify the Representative so that any use of the Disclosure Package may cease until it is amended or
supplemented; (ii)&nbsp;amend or supplement the Disclosure Package to correct such statement or omission; and (iii)&nbsp;supply any amendment or supplement to the Representative in such quantities as they may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Prospectus Delivery</U>. If, at any time when a prospectus relating to the Securities is required
to be delivered under the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then supplemented would include any untrue statement of a material
fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made at such time not misleading, or if it shall be necessary to amend the Registration Statement, file a new
registration statement or supplement the Final Prospectus to comply with the Act or the Exchange Act or the respective rules thereunder, including in connection with use or delivery of the Final Prospectus, the Company will promptly (i)&nbsp;notify
the Underwriters of any such event, (ii)&nbsp;prepare and file with the Commission an amendment or supplement or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
new registration statement which will correct such statement or omission or effect such compliance, (iii)&nbsp;use its reasonable best efforts to have any amendment to the Registration Statement
or new registration statement declared effective as soon as practicable in order to avoid any disruption in use of the Final Prospectus and (iv)&nbsp;supply any supplemented Final Prospectus to the Underwriters in such quantities as they may
reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule 158</U>. As soon as practicable, the Company will make generally
available to its security holders and to the Underwriters an earnings statement or statements of the Company and its subsidiaries which will satisfy the provisions of Section&nbsp;11(a) of the Act and Rule&nbsp;158. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Copies of Documents</U>. The Company will furnish to the Representative and counsel for the
Underwriters, without charge, signed copies of the Registration Statement (including exhibits thereto) and, so long as delivery of a prospectus by the Underwriters or dealer may be required by the Act (including in circumstances where such
requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and any supplement thereto as the Underwriters may reasonably request. The Company will
pay the expenses of printing or other production of all documents relating to the offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Blue Sky</U>. The Company will arrange, if necessary, for the qualification of the Securities for
sale under the laws of such jurisdictions as the Representative may designate and will maintain such qualifications in effect so long as required for the distribution of the Securities; <U>provided</U> that in no event shall the Company be obligated
to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction
where it is not now so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectus</U>. The Company agrees that, unless
it has or shall have obtained the prior written consent of the Representative, and each Underwriter agrees with the Company that, unless it has or shall have obtained the prior written consent of the Company, neither party has made and will not make
any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in Rule 405) required to be filed by the Company with the Commission or
retained by the Company under Rule 433. Any such free writing prospectus consented to by the Representative or the Company is hereinafter referred to as a &#147;<U>Permitted Free Writing Prospectus</U>.&#148; The Company agrees that (x)&nbsp;it has
treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y)&nbsp;it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any
Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Ratings</U>. The Company shall take all reasonable action necessary to enable S&amp;P Global
Ratings, a division of S&amp;P Global, Inc. (&#147;<U>S&amp;P</U>&#148;), and Moody&#146;s Investors Service Inc. (&#147;<U>Moody&#146;s</U>&#148;) to provide their respective credit ratings of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement not to Offer or Sell Additional Securities</U>. During the period from the date hereof
through and including the 90th<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>day following the Closing Date, the Company and each of the Guarantors will not, without the prior written consent of Citigroup Global Markets Inc., offer, sell,
contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company or any of the Guarantors and having a stated maturity of more than one year. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stabilization</U>. Neither the Company nor the Guarantors will take, directly or indirectly, any
action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. The Company and the Guarantors jointly and severally agree to pay the costs and
expenses relating to the following matters: (i)&nbsp;the preparation, printing or reproduction and filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), each
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus, and each amendment or supplement to any of them; (ii)&nbsp;the printing (or reproduction) and delivery
(including postage, air freight charges and charges for counting and packaging) of such copies of the Registration Statement, each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus, and all amendments or
supplements to any of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of the Securities; (iii)&nbsp;the preparation, printing, authentication, issuance and delivery of certificates for the
Securities, including any stamp or transfer taxes in connection with the original issuance and sale of the Securities; (iv)&nbsp;the printing (or reproduction) and delivery of this Agreement, any blue sky memorandum and all other agreements or
documents printed (or reproduced) and delivered in connection with the offering of the Securities; (v)&nbsp;the registration of the Securities under the Act; (vi)&nbsp;any registration or qualification of the Securities for offer and sale under the
securities or blue sky laws of the several states (including filing fees and the reasonable fees and expenses of counsel for the Underwriters relating to such registration and qualification); (vii)&nbsp;any filings required to be made with the
Financial Industry Regulatory Authority, Inc. (including filing fees and the reasonable fees and expenses of counsel for the Underwriters relating to such filings); (viii)&nbsp;the transportation and other expenses incurred by or on behalf of the
Company representatives in connection with presentations to prospective purchasers of the Securities; (ix)&nbsp;the fees and expenses of the Company&#146;s accountants and the fees and expenses of counsel (including local and special counsel) for
the Company and the Guarantors; (x)&nbsp;any fees charged by rating agencies for the rating of the Securities; (xi)&nbsp;the fees and expenses of the Trustee (including related fees and expenses of any counsel to the Trustee); and (xii)&nbsp;all
other costs and expenses incident to the performance by the Company and the Guarantors of their respective obligations under the Transaction Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;<U>Use of Proceeds</U>. The Company will apply the net proceeds of the Securities as described in
the Disclosure Package and the Final Prospectus under the heading &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
to the Obligations of the Underwriter</U>. The obligations of the Underwriters to purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company and the Guarantors contained herein as of the
Execution Time and as of the Closing Date, to the accuracy of the statements of the Company and the Guarantors made in any certificates pursuant to the provisions hereof, to the performance by the Company and the Guarantors of their respective
obligations hereunder and to the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings under the Act</U>.
The Final Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule&nbsp;424(b) and any other material required to be filed by the Company pursuant to Rule 433(d) under the Act, shall
have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement or any notice objecting to its use shall have been issued
and no proceedings for that purpose or pursuant to Section&nbsp;8A of the Act shall have been instituted or threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel for the Company; Opinion of General Counsel of the Company</U>. The
Representative shall have received an opinion, dated the Closing Date, of Maynard Cooper&nbsp;&amp; Gale, P.C., counsel for the Company, of Bradley Arant Boult Cummings LLP, counsel for the Company, and of Patrick Darby, Executive Vice President,
General Counsel and Corporate Secretary of the Company, in the forms agreed upon by the Representative and such persons on the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel for the Representative</U>. The Representative shall have received from Cahill
Gordon&nbsp;&amp; Reindel <SMALL>LLP</SMALL>, counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the Underwriters, with respect to the issuance and sale of the Securities, the Registration Statement, the
Disclosure Package, the Final Prospectus (together with any supplement thereto) and other related matters as the Representative may reasonably require, and the Company shall have furnished to such counsel such documents as they request for the
purpose of enabling them to pass upon such matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&#146; Certificate</U>. The Company
shall have furnished to the Representative a certificate of the Company, signed by a President or Vice President of the Company and the principal financial or accounting officer of the Company, dated the Closing Date, to the effect that the signers
of such certificate have carefully examined the Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or amendments thereto, and this Agreement and that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of the Company and the Guarantors in this Agreement are true and
correct on and as of the Closing Date with the same effect as if made on the Closing Date and the Company and each of the Guarantors has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or
prior to the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;no stop order suspending the effectiveness of the Registration
Statement or any notice objecting to its use has been issued and no proceedings for that purpose or pursuant to Section&nbsp;8A of the Act have been instituted or, to the Company&#146;s or the Guarantors&#146; knowledge, threatened; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;since the date of the most recent financial statements included in the Disclosure Package and the
Final Prospectus (exclusive of any supplement thereto), there has been no Material Adverse Effect, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (exclusive of any supplement thereto). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Comfort Letter</U>. At the time of execution of this Agreement, the Representative shall have
received from PricewaterhouseCoopers LLP, a letter dated such date, which in form and substance satisfactory to the Representative and PricewaterhouseCoopers LLP, containing statements and information of the type ordinarily included in
accountants&#146; &#147;comfort letters&#148; to Underwriters with respect to the financial statements and certain financial information contained in the Disclosure Package. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Bring-Down Comfort Letter</U>. At the Closing Date, the Representative shall have received from
PricewaterhouseCoopers LLP, a letter dated such date, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e)&nbsp;of this Section&nbsp;6, except that the specified dated referred in such letter to
shall be a date not more than three Business Days prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material
Adverse Change</U>. Subsequent to the date of this Agreement or, if earlier, the dates as of which information is given in the Registration Statement (exclusive of any amendment thereof), the Disclosure Package (exclusive of any amendment or
supplement thereto) and the Final Prospectus (exclusive of any amendment or supplement thereto), there shall not have been&nbsp;any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise),
earnings, business or properties of the Company and its subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package (exclusive of any
amendment or supplement thereto) and the Final Prospectus (exclusive of any amendment or supplement thereto) the effect of which, is, in the judgment of the Representative, so material and adverse as to make it impractical or inadvisable to proceed
with the offering, sale or delivery of the Securities as contemplated by the Registration Statement (exclusive of any amendment thereof), the Disclosure Package (exclusive of any amendment or supplement thereto) and the Final Prospectus (exclusive
of any amendment or supplement thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>No Ratings Agency Change</U>. Subsequent to the
Execution Time, (i)&nbsp;there shall not have been any decrease in the rating of any of the Company&#146;s debt securities by any &#147;nationally recognized statistical rating organization&#148; (as such term is defined for purposes of
Section&nbsp;3(a)(62) of the Exchange Act) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change, and (ii)&nbsp;no such
organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any of the Company&#146;s debt securities (other than an announcement with positive
implications of possible upgrading). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Documents</U>. Prior to the Closing
Date, the Company shall have furnished to the Representative such further information, certificates and documents as the Representative may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of the conditions specified in this Section&nbsp;6 shall not have been fulfilled when and as provided in this Agreement, this Agreement
and all obligations of the Underwriters, the Company and the Guarantors, except as provided in Section&nbsp;7 and except that Sections 1, 5(k), 8 and 11 to 22 shall survive any such termination and remain in full force and effect, hereunder may be
canceled at, or at any time prior to, the Closing Date by the Representative. Notice of such cancellation shall be given to the Company in writing or by telephone or facsimile confirmed in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reimbursement of Underwriters&#146; Expenses</U>. If the sale of the Securities provided for herein is not
consummated (i)&nbsp;because a condition to the obligations of the Underwriters set forth in Section&nbsp;6 (excluding Section (c)) hereof is not satisfied, (ii)&nbsp;because of any termination pursuant to Section&nbsp;9 hereof, or
(iii)&nbsp;because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, then, in each case, the Company and
the Guarantors, jointly and severally, agree to reimburse the Underwriters on demand through Citigroup Global Markets Inc. for all expenses (including reasonable fees and disbursements of counsel) that shall have been reasonably incurred by the
Underwriters in connection with the proposed purchase and sale of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification and
Contribution</U>. (a)<I>&nbsp;Indemnification of the Underwriters</I>. The Company and each of the Guarantors, jointly and severally, agree to indemnify and hold harmless each Underwriter, its affiliates, the directors, officers, employees and
agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Act or the Exchange Act, from and against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may
become subject under the Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Securities as originally filed or in any amendment thereof, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or arise out of or are based upon any untrue statement or alleged untrue statement of a material fact
contained in the Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating to the Securities, the Final Prospectus, any Issuer Free Writing Prospectus, or in any amendment thereof or supplement thereto, or
arise out of or are based upon the omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and agrees to reimburse each such
indemnified party, as incurred, for any legal or other expenses (including the fees and disbursements of counsel chosen by Citigroup Global Markets Inc.) reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability or action; <U>provided</U>, <U>however</U>, that the Company and the Guarantors will not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon any such untrue
statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for inclusion therein, which
information consists solely of the information specified in paragraph (b)&nbsp;of this Section&nbsp;8. This indemnity agreement will be in addition to any liability which the Company or the Guarantors may otherwise have. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of the Company</I>. Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement, and each person who controls the Company within the meaning of either the Act or the Exchange Act, to the same extent as the
foregoing indemnity from the Company and the Guarantors to the Underwriters, but only with reference to written information relating to the Underwriters furnished to the Company by or on behalf of the Underwriters specifically for inclusion in the
documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability which the Underwriters may otherwise have. The Company acknowledges and agrees that the only written information furnished by the
Underwriters consists of the paragraphs in the Disclosure Package and the Final Prospectus under the heading &#147;Underwriting (Conflicts of Interest)&#148; related to short sales, market making, stabilization, penalty bids, and purchases to cover
positions created by short sales. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice and Procedures</I>. Promptly after
receipt by an indemnified party under this Section&nbsp;8&nbsp;of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;8, notify the
indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i)&nbsp;will not relieve the indemnifying party from liability under paragraph&nbsp;(a)&nbsp;or&nbsp;(b)&nbsp;above unless and to the
extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and&nbsp;(ii)&nbsp;will not, in any event, relieve the indemnifying party from any obligations
to any indemnified party other than the indemnification obligation provided in paragraph&nbsp;(a)&nbsp;or (b)&nbsp;above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party&#146;s choice at the indemnifying
party&#146;s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the
indemnified party or parties except as set forth below); <U>provided</U>, <U>however</U>, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party&#146;s election to appoint counsel to
represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel) (which counsel and local counsel will, in connection with any indemnification pursuant to Section&nbsp;8(a)
hereof, be chosen by Citigroup Global Markets Inc.), and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i)&nbsp;the use of counsel chosen by the indemnifying party to represent the indemnified
party would present such counsel with a conflict of interest, (ii)&nbsp;the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall have
reasonably concluded that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, (iii)&nbsp;the indemnifying party shall not have employed
counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action or (iv)&nbsp;the indemnifying party shall authorize the indemnified party to employ
separate counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or
threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement,
compromise or consent (x)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding, and (y)&nbsp;does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution</I>.
In the event that the indemnity provided in paragraph&nbsp;(a) or (b)&nbsp;of this Section&nbsp;8&nbsp;is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company and the Guarantors jointly and severally agree
and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively
&#147;<U>Losses</U>&#148;) to which the Company, the Guarantors and the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors on the one hand and by the
Underwriters on the other from the offering of the Securities. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company, the Guarantors and the Underwriters shall contribute in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of the Company and the Guarantors on the one hand and of the Underwriters on the other in connection with the statements or omissions which resulted in such Losses as
well as any other relevant equitable considerations. Benefits received by the Company and the Guarantors shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by the Company, and benefits
received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be determined by reference to, among other
things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company and the Guarantors on the one hand or the Underwriters on the
other, the intent of the parties and their relative knowledge, access to information and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
opportunity to correct or prevent such untrue statement or omission. The Company, the Guarantors and the Underwriters agree that it would not be just and equitable if contribution pursuant to
this Section&nbsp;8 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph&nbsp;(d), no person
guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;8, each person
who controls an Underwriter within the meaning of either the Act or the Exchange Act and each affiliate, director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who
controls the Company within the meaning of either the Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company,
subject in each case to the applicable terms and conditions of this paragraph (d). In no case shall the Underwriters be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by the
Underwriters hereunder. Each Underwriter&#146;s respective obligation to contribute pursuant to this Section&nbsp;8 is several in proportion to its respective purchase obligations hereunder and not joint. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated in the absolute discretion of the
Representative, by notice to the Company, if after the execution and delivery of this Agreement and prior to the delivery of and payment for the Securities, (i)&nbsp;trading generally shall have been suspended or materially limited on the New York
Stock Exchange or the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (ii)&nbsp;trading of any securities issued by the Company shall have been suspended on any exchange or in any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; (iv)&nbsp;a
material disruption in commercial banking or securities settlement or clearance services in the United States shall have occurred; or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a
national emergency or war, that, in the judgment of the Representative, makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the Closing Date on the terms and in the manner contemplated by this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter defaults on its
obligation to purchase the Securities that it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory
to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Securities, then
the Company shall be entitled to a further period of 36 hours within which to procure other persons reasonably satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms. If
other persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full business
days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to
promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#147;<U>Underwriter</U>&#148; includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;10, purchases Securities&nbsp;that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a defaulting
Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not
exceed <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase
the principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s pro&nbsp;rata share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities
of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for
the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such
Securities that remains unpurchased exceeds <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this
Agreement shall terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the
Company or the Guarantors, except that the Company and the Guarantors will continue to be liable for the payment of expenses as set forth in Section&nbsp;7 hereof and except that the provisions of Section&nbsp;8 hereof shall not terminate and shall
remain in effect; <U>provided</U>, <U>however</U>, that the Company shall not be liable for the payment of expenses incurred by any defaulting Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the
Company or any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Indemnities to Survive</U>. The respective agreements, representations, warranties,
indemnities and other statements of the Company, the Guarantors, the Company&#146;s officers and of the Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of the Underwriters or the Company, the Guarantors or any of the affiliates, officers, directors, employees, agents or controlling persons referred to in Section&nbsp;8 hereof, and will survive delivery of and payment for the Securities. The
provisions of Sections&nbsp;5(k), 7 and 8 hereof shall survive the termination or cancellation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder shall be in writing and effective only on receipt,
and, if sent to the Underwriter, will be mailed or transmitted by any standard form of telecommunication, to Citigroup Global Markets Inc. at 388 Greenwich Street, New York, New York 10013, Attention: General Counsel; or, if sent to the Company,
will be mailed or transmitted by any standard form of telecommunication to the Company at 9001 Liberty Parkway, Birmingham, AL 35242, Facsimile: <FONT STYLE="white-space:nowrap">(205)&nbsp;262-8692,</FONT> attention of Patrick Darby, Executive Vice
President, General Counsel and Corporate Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors</U>. This Agreement will inure to the
benefit of and be binding upon the parties hereto and their respective successors and the affiliates, officers, directors, employees, agents and controlling persons referred to in Section&nbsp;8 hereof, and no other person will have any right or
obligation hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Fiduciary Duty</U>. The Company and the Guarantors hereby acknowledge that
(a)&nbsp;the purchase and sale of the Securities pursuant to this Agreement is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company and the Guarantors, on the one hand, and the Underwriters and any
affiliate through which they may be acting, on the other, (b)&nbsp;the Underwriters are acting as principals and not as agents or fiduciaries of the Company and the Guarantors and (c)&nbsp;the Company&#146;s and the Guarantors&#146; engagement of
the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, the Company and each Guarantor agrees that it is solely responsible for making its
own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company or any Guarantor on related or other matters). The Company and each Guarantor agrees that it will not
claim that the Underwriters have rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company or to any Guarantor, in connection with such transaction or the process leading thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT
STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include
the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Integration</U>. This Agreement supersedes all prior agreements and understandings (whether written or oral)
between the Company and the Guarantors, on the one hand, and the Underwriters, on the other hand, or any of them, with respect to the subject matter hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law</U>. This Agreement and any claim, controversy
or dispute arising under or relating to this Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New&nbsp;York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. The Company and each Guarantor hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special
Resolution Regime, the transfer of this Agreement, and any interest and obligation in or under this Agreement, from such Underwriter will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if
this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes
subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under
the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For
purposes of this Section&nbsp;19, a &#147;<U>BHC Act Affiliate</U>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#147;<U>Covered Entity</U>&#148; means
any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with,
12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#147;<U>Default Right</U>&#148; has the meaning assigned to that term in, and shall be
interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;<U>U.S. Special Resolution Regime</U>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and
(ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Agreement may be signed in one or more counterparts, each of which shall constitute an
original and all of which together shall constitute one and the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The section
headings used herein are for convenience only and shall not affect the construction hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. The terms that follow, when used in this Agreement, shall have the meanings indicated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Act</U>&#148; shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Prospectus</U>&#148; shall mean the base prospectus referred to in Section&nbsp;1(a)
above contained in the Registration Statement at the Execution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; shall mean any
day&nbsp;other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated by law to remain closed in New York City, New York. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commission</U>&#148; shall mean the Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Package</U>&#148; shall mean (i)&nbsp;the Base
Prospectus, (ii)&nbsp;the Preliminary Prospectus used most recently prior to the Execution Time, (iii)&nbsp;any Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package,
and (iv)&nbsp;each Free Writing Prospectus listed on Annex A hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; shall mean each
date and time that the Registration Statement, and any post-effective amendment or amendments thereto became or is deemed to become effective. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of
the Commission promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Execution Time</U>&#148; shall mean 4:15 p.m. (EDT) on September&nbsp;9,
2019. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Prospectus</U>&#148; shall mean the prospectus supplement relating to the Securities that was first
filed pursuant to Rule 424(b) after the Execution Time, together with the Base Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Free Writing
Prospectus</U>&#148; shall mean a free writing prospectus, as defined in Rule 405. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer Free Writing
Prospectus</U>&#148; shall mean an issuer free writing prospectus, as defined in Rule&nbsp;433. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preliminary
Prospectus</U>&#148; shall mean any preliminary prospectus supplement to the Base Prospectus referred to in Section&nbsp;1(a) above which is used prior to the Execution Time, together with the Base Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; shall mean the registration statement referred to in Section&nbsp;1(a) above,
including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430B, as amended on each
Effective Date and, in the event any post-effective amendment thereto becomes effective prior to the Closing Date, shall also mean such registration statement as so amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule 158</U>,&#148; &#147;<U>Rule 163</U>,&#148; &#147;<U>Rule 164</U>,&#148; &#147;<U>Rule 172</U>,&#148;
&#147;<U>Rule 405</U>,&#148; &#147;<U>Rule</U><U></U><U>&nbsp;415</U>,&#148; &#147;<U>Rule</U><U></U><U>&nbsp;424</U>,&#148; &#147;<U>Rule 430B</U>,&#148; and &#147;<U>Rule 433</U>&#148; refer to such rules under the Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trust Indenture Act</U>&#148; shall mean the Trust Indenture Act of 1939, as amended, and the rules and regulations of
the Commission promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Well-Known Seasoned Issuer</U>&#148; shall mean a well-known seasoned
issuer, as defined in Rule 405. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company, the Guarantors and the several Underwriters. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:12pt ;">Encompass Health Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Doulas E. Coltharp</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Douglas E. Coltharp</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GUARANTORS</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health C Corp Sub Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Central Arkansas Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Jonesboro Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Columbia, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Concord, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Dothan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Florence, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Manati, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Panama City, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of San Juan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Tyler Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Yuma Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of City View, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of San Antonio, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of Texarkana, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of The Woodlands, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of Austin, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Rehab Concepts Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Reliant Blocker Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Western Neuro Care, Inc.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Northwest Tucson,&nbsp;L.P.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Partner</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tustin,
L.P.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of North Houston, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">HealthSouth North Houston GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Partner</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Continental Medical Systems, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Acquisition Holdings Subsidiary, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Acquisition Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Alabama Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Arizona Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Arkansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Boise Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Bryan Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health California Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Colorado Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Deaconess Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Fairlawn Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health GKBJH Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Gulfport Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Iowa Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Johnson City Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Joint Ventures Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Kansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Kentucky Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Littleton Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Lubbock Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Martin County Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Maryland Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Massachusetts Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Midland Odessa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Myrtle Beach Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Nevada Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health New Mexico Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health North Houston GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Ohio Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Owned Hospitals Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Pennsylvania Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Properties, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bluffton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Braintree, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Charleston, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Dayton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of East Valley, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Erie, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Franklin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Gadsden, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Harmarville, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Henderson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Kingsport, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Lakeview, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Largo, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Littleton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Miami, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Middletown, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Modesto, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Newnan, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Ocala, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Petersburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Reading, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sarasota, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Shelby County, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sunrise, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Toms River, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Utah, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Vineland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of York, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Institute of Tucson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Savannah Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Sea Pines Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Sewickley Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health South Carolina Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health South Dakota Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Support Companies, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Texas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Tucson Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Tulsa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Utah Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Walton Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health West Tennessee Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health West Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Westerville Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Winston-Salem Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Abilene, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Arlington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Austin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Cypress, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Dallas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Humble, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Pearland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Richardson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Round Rock, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of Sugar Land, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Rehabilitation Hospital The Vintage, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Promotions Group, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Rebound, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital Corporation of America, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital of North Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of Plano, LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted and agreed to as of the date</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">first written above</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as Representative and Underwriter</I></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stuart Dickson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stuart Dickson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Barclays Capital Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Burton</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Benjamin Burton</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BofA Securities, Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter</I></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew Curtin</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew Curtin</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ariel Fox</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ariel Fox</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bradford D. Garvey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bradford D. Garvey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Graham T. Robertson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Graham T. Robertson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James S. Wolfe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James S. Wolfe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director, Head of Global</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Leveraged Finance</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regions Securities LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Neil P. Giardino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Neil P. Giardino</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SunTrust Robinson Humphrey, Inc., </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chris White</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chris White</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen M. Neill</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen M. Neill</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal Amount<br>of 2028 Notes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal Amount of<BR>2030 Notes</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regions Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SunTrust Robinson Humphrey, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,250,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">500,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">500,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Rehabilitation Hospital of Arizona, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health C Corp Sub Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Central Arkansas Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Jonesboro Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health North Houston GP, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Charleston, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Columbia, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Concord, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dayton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dothan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Tennessee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Manati, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Panama City, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Juan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tustin, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tyler Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Yuma Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Abilene, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Arlington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of City View, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Cypress, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Dallas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Humble, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Pearland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Richardson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Round Rock, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of San Antonio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Sugar Land, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Texarkana, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT>
LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of The Woodlands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital The Vintage, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Austin, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of North Houston, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rebound, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehab Concepts Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital Corporation of America, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of North Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reliant Blocker Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Western Neuro Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX A </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Term sheet containing the terms of the Securities in the form of Annex B. </P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING TERM SHEET </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The free writing prospectus filed on September&nbsp;9, 2019 by the Company with the SEC pursuant to Rule 433.
</P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d795128dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g795128g0911111610986.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hillary Carnel | 205 <FONT STYLE="white-space:nowrap">970-5912</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">hillary.carnel@encompasshealth.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations
Contact: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Crissy Carlisle | 205 <FONT STYLE="white-space:nowrap">970-5860</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">crissy.carlisle@encompasshealth.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Encompass
Health prices offering of its 4.500% senior notes due 2028 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and its 4.750% senior notes due 2030 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BIRMINGHAM, Ala., Sept. 9, 2019</B> &#150; Encompass Health Corporation (NYSE: EHC) today announced the pricing of its underwritten public offering
of&nbsp;$500 million&nbsp;in aggregate principal amount of its 4.500% senior notes due 2028 at a public offering price of 100% of the principal amount and $500 million&nbsp;in aggregate principal amount of its 4.750% senior notes due 2030 at a
public offering price of 100% of the principal amount. The Company will pay interest on both series of the notes semi-annually in arrears on&nbsp;February 1&nbsp;and&nbsp;August 1&nbsp;of each year, beginning on&nbsp;February 1, 2020. The notes will
be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company&#146;s credit agreement and other capital markets debt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company intends to use the net proceeds from this offering to fund the purchase of equity from management investors of its home health and hospice
segment, to fund a call of $400&nbsp;million of its senior notes due 2024 and to repay borrowings under its revolving credit facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup;
Barclays; BofA Merrill Lynch; Goldman Sachs&nbsp;&amp; Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This debt offering is being made pursuant to an effective shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-220519)</FONT> filed with the Securities and Exchange Commission. This offering is being made solely by means of a prospectus supplement and accompanying prospectus which has been filed with the SEC. Before
you invest, you should read the prospectus supplement and accompanying prospectus, as well as other documents the Company has filed or will file with the SEC for more complete information about the Company and this offering. You may get these
documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send the prospectus relating to the offering to you if you request it by
contacting Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (800) <FONT STYLE="white-space:nowrap">831-9146</FONT> or email: Prospectus@citi.com; Barclays, c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, NY 11717, email at Barclaysprospectus@broadridge.com, telephone: (888) <FONT STYLE="white-space:nowrap">603-5847;</FONT> BofA Merrill Lynch, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">NC1-004-03-43,</FONT></FONT></FONT> 200 North College Street, 3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> Floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by email at
dg.prospectus_requests@baml.com, or telephone: (800) <FONT STYLE="white-space:nowrap">294-1322;</FONT> Goldman Sachs&nbsp;&amp; Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-471-2526,</FONT></FONT></FONT> facsimile: (212) <FONT STYLE="white-space:nowrap">902-9316</FONT> or by emailing <FONT STYLE="white-space:nowrap">Prospectus-ny@ny.email.gs.com;</FONT>
J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by calling (866) <FONT STYLE="white-space:nowrap">803-9204;</FONT> Morgan Stanley&nbsp;&amp; Co. LLC, at 180 Varick Street, 2nd Floor, New York, NY
10014, Attention: Prospectus Department, by telephone at (866) <FONT STYLE="white-space:nowrap">718-1649</FONT> or by emailing prospectus@morganstanley.com; RBC Capital Markets, Brookfield Place, 200 Vesey Street, 8<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, New York, New York 10281, Attention: Leveraged Capital Markets, or by telephone at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-877-280-</FONT></FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
1299; Regions Securities LLC, 615 S. College Street 6<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, Charlotte, NC 28202, or calling <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">704-940-5066;</FONT></FONT> SunTrust Robinson Humphrey, 3333 Peachtree Road, 10th Floor, Atlanta, GA 30326, <FONT STYLE="white-space:nowrap">e-mail:</FONT> STRHdocs@SunTrust.com, telephone: (800) <FONT
STYLE="white-space:nowrap">685-4786</FONT> or Wells Fargo Securities LLC, Attn: WFS Customer Service, 608 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Ave S, Suite 1000, Minneapolis, MN 55402, or (800)
<FONT STYLE="white-space:nowrap">645-9751</FONT> Opt 5, or email: wfscustomerservice@wellsfargo.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release is for informational purposes
only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.
This press release shall not constitute a notice of redemption with respect to the notes being redeemed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Encompass Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network
of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 133 hospitals, 245 home health locations, and 82 hospice locations in 37 states and Puerto Rico, the Company is committed to
delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune&#146;s 100 Best Companies to Work For. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Statements contained in
this press release which are not historical facts are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All
such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future
events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are
not limited to, Encompass Health&#146;s ability to consummate the offering of notes on the terms described or at all; Encompass Health&#146;s ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any
adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents
affecting the proper operation, availability, or security of Encompass Health&#146;s information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in
connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health&#146;s services by governmental or private payors; and other factors which may be identified from time to time in Encompass
Health&#146;s SEC filings and other public announcements, including Encompass Health&#146;s Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended Dec. 31, 2018 and Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters
ended March&nbsp;31, 2019 and June&nbsp;30, 2019. </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ehc-20190909.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/12/2019 12:26:07 AM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:ehc="http://www.encompasshealth.com/20190909"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.encompasshealth.com/20190909"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20190909_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20190909_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ehc-20190909_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/12/2019 12:26:07 AM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ehc-20190909_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/12/2019 12:26:07 AM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ehc-20190909.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g795128g0911111610986.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g795128g0911111610986.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D /8# 2(  A$! Q$!_\0
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MT*>*?'!ZI<_^ (_^)IUOK7M'R327]>1X$'@N1>UIR;\O^'-1?A?=#_F)P_\
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MEU96]_+>+<3><6D0*5. ,<?2H/AIX^7Q_H$EX]J+6ZMY/*FC5LKG&01[5VM
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MQ^7'0@YR"/6@#S;Q%K6F:M\ ;Q-/OX+EH+*))EB<,8VRO##L:T?A9_R1*/\
MZ]Y_ZUO:9\+?"6E:/?:5;:<YM+X 7"O<.2X'(&<\?A6[I7A[2]%T0:-I]MY-
M@%91%O9N&Z\DD_K0!Y-^SI_R"=>_Z_1_Z"*]MK$\.>$=#\)PW$6B67V5+A_,
ME'F.^YO7YB:VZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (!ZBDVK_
M '1^5+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6627163216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 09, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  09,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>d795128d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20190909.xsd" xlink:type="simple"/>
    <context id="duration_2019-09-09_to_2019-09-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2019-09-09_to_2019-09-09"
      id="Hidden_dei_EntityRegistrantName">Encompass Health Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2019-09-09_to_2019-09-09">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2019-09-09_to_2019-09-09"
      id="Hidden_dei_EntityCentralIndexKey">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2019-09-09_to_2019-09-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2019-09-09_to_2019-09-09">2019-09-09</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2019-09-09_to_2019-09-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2019-09-09_to_2019-09-09">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2019-09-09_to_2019-09-09">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2019-09-09_to_2019-09-09">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2019-09-09_to_2019-09-09">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2019-09-09_to_2019-09-09">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2019-09-09_to_2019-09-09">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2019-09-09_to_2019-09-09">(205)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2019-09-09_to_2019-09-09">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2019-09-09_to_2019-09-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2019-09-09_to_2019-09-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2019-09-09_to_2019-09-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2019-09-09_to_2019-09-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2019-09-09_to_2019-09-09">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2019-09-09_to_2019-09-09">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2019-09-09_to_2019-09-09">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2019-09-09_to_2019-09-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-19-242991-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-242991-xbrl.zip
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M]I4G,P_MSQO<#$%1GEXW3]F;C6&F';GA\=B/2(>D'$CS)(N-P>M2)? )R#.
M,U?E3SO!_<ZJ&E;G$XR5F]GUOM8E6Y\:H L&N]M3@7-7)F"4R#WU(D;^854M
MFX1X%V6THD;H>SP\?NI^QSK*:(GMKY]][KQO9)YQ$V?S,=?YECQ^5%;) 2[B
M]=^!N#.LG3JU*_?_=;S4"]]%'YZ1_HPX^O0&NMR!LF.Z^&WAR(1+ DXXQ $X
MRY ,13!1(Z++3/T9UFRZ;,!]4[%I<LS6?N+3+B283>&U+BS?,%ZH]RMI\FUY
MSJ*J[BKI%H-J&#EFYQ<)+LUI?++\)[UZQRS^;>/*+>SF,W#38 U_X.EJ(;/Q
MI:.Y$; 2\R \ E;R QTL19+I7@!C? "()?_<'&WH4G?<)[V6-\/%)QR61K;T
M 4%H$>R>2Q@'#$I]!S/ U'&PO!4[XX5HEPI7FJ,_=VVDUMBA::269;OJL[%5
M2M(B$FY2<?#X(^OW*XD(VLKKB7JB4CO3G8 I1&N8]/QGQOGK,^!)</Z\"9W)
M?YIR>[PCGSJ*$(\'HO534_\Y3K&<9E P=^#U*H^\F_I"R<8E<_T=91]M:_/T
MXX5BXUCRP26MDBV3=.N\FD=F[;I8DX^E$ &A)#G'(^=H>[FNACH;"J:S=54#
MK E1GNA<Z&=0X3 M9F^WL0XZ\7T%7G[AK:$R67=5A>R@GL6:G;IUW$GL-SS9
MQ[N@WUW@8J$HUQ4>7$DBHSZ0GU/!L1P,#,DPHFA4 B')3CS-I_2K9*8RT9I'
MNRZXK;[)1TZ$.36DR8;FH/DMVR7=\Q0X;8$ZT IV, K))R\ JPWT$G<,X+SP
MG2K Y^C!@&:?C:@WB+%@WD#C1C%Y& HF85ZJ21O;'<F ?6&V%$H&Z*'[X6*S
M8+ ?.RA_:+CNF0?&MPANEMT 7 \[95O+.3-H0F#LTTE</D1:%^-P3)_K.0!X
M#[]9G(O\8]^RRI;Y"R-AZ!"=@3 MYZ-CM,<)BAE:ZVJM/5#UUL_ 0SX'<WX9
M*.!6%]:L6_6C'%GT%[H]QR=/7OYPOWCYAK6P/'R171Y7A_T/AL:GUFR!_>=P
MYJB3AQP(F65&K.L(H[X'SF: AQ3(/ E77\5?)&.KY!9F-9".*/!.'P(3,VS!
MOZ'H]N!]*Q6A (6A9Y@=;_ZY*Z4VIG%F:&%_^T@/.$0DJ=+>K,05J5BYUPQ@
MU(R;7@G3FD 7W6K L)1\HR*R7J513H(&$"8Z-L[CCBE$#ZH/3F!P:#0:%=CB
M?;NY6\X4I<%,_5E.(%+B9D(39+[43\P4PZ\LOHECHW(&8D/+A,(8B+%I:!QD
M((/C!> >8Y6;(+0?1&H%#8!HH![_%\8EQ#-%<S2]W>1$$O0W!?."<^)2$*RX
MVLV6U6VN"SZC];"UGW:;52<YA:OC*;  ,@-]5FL"Z&4RH0)5?D(/)[AG$ <H
MN<""J1:<FXAR9@N2S8;U=3C#QOZ\JG]>;;C!K(7JUGS)L#C=3(G/@=8:<]3F
MQ8F&*=#%' :X(RZ3CN!AMMYQQ8X!_V!<E:VF[#,3/#%EU#AT^2L" B8W,-&V
MXB4&P=0,N3Y]*\V2KL\M!4P,\X:ZR-+8#TPB*$4A '0)FBK4/QB_CWB?*V)7
M[61YGMZTBWL"%-F%WQ _)K3+^"*P)1RD<8"EJ#15P1"JH@)DKK&W8XI^G*D^
MC50DT@YE<@\>3  Z51^^"A.PXK[X]TPJ3<0^]>^T<^+GHEH7N", /I%,W&--
MO(Z+%YD1J3F'K:S[I.9]9F 5S&&@@UW4*LN QJT9QARP6+A0-?F2Q?P9+6Q2
M#</T-?N$-X)1\0T9BF<\P-/G\C*C,Q=MA@-&#?AG[JDA) F0VI<2+*<T5R 0
M[Q; E&X@0#-!IT9[8WS<!\MIEAAD4)DCO56\?O32-2%_OS#MZ(V$:>;^<!??
MW""_DT LJR:T1^]JWQ OW@CF,2I1E'QPDY$Y8^^/Z\^QO4D\%"/ZBS*:GPE4
MO/&A,NJ_V03];ZQ"^=%VX%WBOK'$-=^(Q'U,K6 :*B3NMV:O!\7PO7SO^<OW
M=MS=UREN2XA>2/,W_<Z&S%N#-B^M6E5'M;HL:G]MT52S/F]^>M44; ^&S:>E
M>FEUN+VB&"7#"IWNY6WWYA7+4Y:N[RW6TR0OHS4O^*WTO<"Y2WGQI"](K6UN
M&\96JV#[-]V7)>1BOHUY9)-7:A6"N\51_\/U1W\G*I_G _#$J<D0ND"0,NJD
MH"8H/A,Z @VQ9I/?4*_G*X=ZF'/RA28/<LA6UN,)#)T':\&0;<?4V]2Z9(^?
M,8WR>/V206 ;7;)=A="+UQ-E+:A5M2PV7AM*Q5VVWG9R0HEYN[1[V-RWZT<N
MF]IV=:3&I?:JG-CZQ'K?Y&CH.(!1Z\[&ROD3KUGVK"MW&%1^\!QJZ: IR1JM
M.6'2B2?H9@ZL3+SV@0H'%*,D'1IR!>N8^3\$@[-,FKL<?_T)E#60BO2H,Y()
M_UJ-HV/ LDJ^?.F4R;^KUU7R-1!#[#;/D^NVY&M%?8_-BL???.BDL,0XE^,6
M-M2YVL59>Y%_*R*I@(WZH*] EW^.QB&0>&; UGC^CFXC^0B\$.3P@AE YFC[
M7>F_*_UOH?1UPN1=T[^:IF\V8U5_K7-;-W%N"[V_M8I[G05X5R#O"N2;*1#;
MVGO7']]&?W0" )=< U^#'P'^%#4U#N=44?-F/)THMX^UW^7HSB@$A..O"2**
M#J4YQ *%X>*I+18;Q(=R%SH.);JC&[\!>EF#S#.>&]8XZJI#TTU7.7X'U8ZO
M=]>@=_'I\NSVMYMN[U4/IK.O<3=UU7]%7,3)\,T*Y\U!T$V^(-N-O!EQ:"1U
M!,#1UNF7E9O: 0D(X%&Q*12(B]GBXA@=0L0=,'2(L,1.3P<T&P4"L'.30YPL
MT;V JI;6*ED.><W<[=XSI&[U*[K67(JUZT^XZ7IT^,2D;=ZFIEG;1NEY->YS
M'_Z4VMW+SM77Z[->CWSNGGVY_4PZ5S?75S=GMQ=7E\_A2]D'&[DVC^_VUNX1
M/IDB'V:ME9[%:UCY183R&"#IBU%<E1->N'90:M=DK>!=%5C( SJT)<?4\RH.
MZ)E2^SR(AAX>>U<A*H#8@.)O@<M<]O@Q&0+OV+UMEM@:I0)"/J!LOF\2ZDN^
M/Q@-YV^1_2_N,(*!O/YM=CK/UQEQ-B#SP@+SHEFQSK=>ON'D>(P*/.<:E;9[
M)6<N,/EY?5#R&%\1?S=,:YZ%(+:=9B#"QT<))S7]6SI/]._P;/\_4$L#!!0
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M'R%L?[/6T+#+&OJ(&7I4A8=@H.;(N&SS[,3RK3,4 C91$TB>)A3#!D13:K-
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M]818WS-D\>;H#(Z"</!'UTX%UQW,[G.X$2D9EQD866 R<EA35B#GP]V/S#_
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MN IG6HFMN?0",2OX<0;[<D6O@\+Z-^$8T-@6<J%0*EUF,0?41G&!Z&;X4/B
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MS1J[!B2:UVL*]W5+D[P9@7%,-D,UH9.C@JK"D[<:(CUOOOEHE<+VEM8*1P2
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MSE,>!.5,@M:OR,]5*O7Y3N\@PPGA3-+8-A*.V4%%7Y7'KWO:_\&.VMWYY<!
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M;0SM<#F(P1'!F9)E8A&[JKP4 !N!'4]X0_0@.[37DTX-^0ZNUR2FQZ5\&3H
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M.34Q,CAD97@Q,2YH=&U02P$"% ,4    "  $A"M/.:J*?=0.  !R*P  $0
M            @ &<BP  9#<Y-3$R.&1E>#DY,2YH=&U02P$"% ,4    "  $
MA"M/).0[,&<#   Y#   $               @ &?F@  96AC+3(P,3DP.3 Y
M+GAS9%!+ 0(4 Q0    (  2$*T]+E#.6908  $E$   4              "
M 32>  !E:&,M,C Q.3 Y,#E?;&%B+GAM;%!+ 0(4 Q0    (  2$*T]VH"Y]
MOP0  !0K   4              "  <ND  !E:&,M,C Q.3 Y,#E?<')E+GAM
7;%!+!08     !@ & 'L!  "\J0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W$W;>V(/]Q\970=G"K[N07U!+ P04    "  $A"M/F5R<(Q &  "<)P
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M7H(PK8>_R43]-<#JUV5?4$L#!!0    (  2$*T\+C]@#(0$  %<$   3
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M+G)E;'-02P$"% ,4    "  $A"M/)^B'#H(   "Q    $
M@ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  2$*T^9-V_9[@
M "L"   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    (  2$*T^97)PC$ 8  )PG   3              "  ;8"  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ !(0K3PNJG*V: @  DPL  !@
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9>&UL4$L%!@     *  H @ (   ,4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d795128d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d795128d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20190909_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20190909_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20190909.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20190909",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d795128d8k.htm",
      "contextRef": "duration_2019-09-09_to_2019-09-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d795128d8k.htm",
      "contextRef": "duration_2019-09-09_to_2019-09-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d795128d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com//20190909/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d795128d8k.htm">d795128d8k.htm</File>
    <File>d795128dex11.htm</File>
    <File>d795128dex991.htm</File>
    <File>ehc-20190909.xsd</File>
    <File>ehc-20190909_lab.xml</File>
    <File>ehc-20190909_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
